Results 1 to 10 of about 4,380 (198)
Repurposing Drugs for Mayaro Virus: Identification of EIDD-1931, Favipiravir and Suramin as Mayaro Virus Inhibitors. [PDF]
Microorganisms, 2021 Despite the emerging threat of the Mayaro virus (MAYV) in Central and South-America, there are no licensed antivirals or vaccines available for this neglected mosquito-borne virus.
Langendries L +3 more
europepmc +7 more sources
Mouse Models of Mayaro Virus. [PDF]
Viruses, 2023 Mayaro virus (MAYV), the etiologic agent of Mayaro fever, leads patients to severe myalgia and arthralgia, which can have a major impact on public health in all the countries where the virus circulates. The emergence and dissemination of new viruses have
Rosa RB +4 more
europepmc +4 more sources
Mayaro Virus Pathogenesis and Transmission Mechanisms [PDF]
Pathogens, 2020 Mayaro virus (MAYV), isolated for the first time in Trinidad and Tobago, has captured the attention of public health authorities worldwide following recent outbreaks in the Americas.
Cheikh Tidiane Diagne +5 more
doaj +7 more sources
EDIS, 2021 Mayaro virus (MAYV) can be spread from mosquitoes to humans. The geographic distribution of Mayaro virus is expanding from South and Central America into the Caribbean Islands, which means that, under the right conditions, this virus could one day ...
Lawrence E Reeves, Lindsay Campbell
doaj +6 more sources
Memorias do Instituto Oswaldo Cruz, 1993 Mayaro virus was grown in BHK-21 cells and purified by centrifugation in a potassium-tartrate gradient (5-50%). The electron microscopy analyses of the purified virus showed an homogeneous population of enveloped particles with 69 ñ 2.3 nm in diameter ...
J. M. S. Mezencio, M. A. Rebello
doaj +4 more sources
Favipiravir Inhibits Mayaro Virus Infection in Mice. [PDF]
Viruses, 2021 Mayaro virus (MAYV) is an emergent alphavirus that causes MAYV fever. It is often associated with debilitating symptoms, particularly arthralgia and myalgia. MAYV infection is becoming a considerable health issue that, unfortunately, lacks a specific antiviral treatment.
Bengue M +9 more
europepmc +6 more sources
Mayaro virus pathogenesis and immunity in rhesus macaques. [PDF]
PLoS Negl Trop Dis, 2023 Mayaro virus (MAYV) is a mosquito-transmitted alphavirus that causes debilitating and persistent arthritogenic disease. While MAYV was previously reported to infect non-human primates (NHP), characterization of MAYV pathogenesis is currently lacking. Therefore, in this study we characterized MAYV infection and immunity in rhesus macaques. To inform the
Weber WC +22 more
europepmc +4 more sources
Mayaro Fever Virus, Brazilian Amazon
Emerging Infectious Diseases, 2009 In February 2008, a Mayaro fever virus (MAYV) outbreak occurred in a settlement in Santa Barbara municipality, northern Brazil. Patients had rash, fever, and severe arthralgia lasting up to 7 days.
Raimunda S.S. Azevedo +9 more
doaj +3 more sources
Re-emergence of mayaro virus and coinfection with chikungunya during an outbreak in the state of Tocantins/Brazil. [PDF]
BMC Res Notes, 2022 Objective To perform a molecular screening to detect infections by the mayaro virus and possible coinfections with Chikungunya during an outbreak in the state of Tocantins/Brazil in 2017.
Dos Santos Souza Marinho R +10 more
europepmc +2 more sources
Mayaro Virus: An Emerging Alphavirus in the Americas. [PDF]
VirusesMayaro virus (MAYV) is an arbovirus first isolated in Trinidad and Tobago in 1954. MAYV is the causative agent of Mayaro fever, which is characterised by high fever, maculopapular rash, myalgia and arthralgia. The potential for chronic arthralgia is of particular clinical concern.
Wei LLL, Tom R, Kim YC.
europepmc +5 more sources